Transamerica Financial Advisors’s Halozyme HALO Stock Holding History

Transamerica Financial Advisors’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.63K	Buy	72 +39	+118%	+$2.66K	﹤0.01%	1097
2026 Q1	$2.13K	Sell	33 -8	-20%	-$564	﹤0.01%	1195
2025 Q4	$2.76K	Buy	41 +27	+193%	+$1.82K	﹤0.01%	1074
2025 Q3	$1.03K	Buy	+14	New	+$930	﹤0.01%	1165
2016 Q2	–	Sell	-1,100	Closed	-$11K	–	524
2016 Q1	$11K	Sell	1,100 -300	-21%	-$2.82K	﹤0.01%	538
2015 Q4	$25K	Buy	1,400 +800	+133%	+$12.8K	﹤0.01%	491
2015 Q3	$9K	Hold	600	–	–	﹤0.01%	594
2015 Q2	$14K	Hold	600	–	–	﹤0.01%	593
2015 Q1	$9K	Buy	600 +300	+100%	+$4.33K	﹤0.01%	636
2014 Q4	$3K	Buy	+300	New	+$2.67K	﹤0.01%	586

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Transamerica Financial Advisors's HALO Position: Q2 2026 in Review

Transamerica Financial Advisors increased its Halozyme (HALO) stake by 118% in Q2 2026, buying an estimated $2.66K and bringing the position to 72 shares worth $5.63K. The position accounts for ﹤0.01% of the portfolio, ranked #1097.

Transamerica Financial Advisors first reported a position in HALO in Q4 2014 and has held it in 10 quarters since. The position peaked at $25K in Q4 2015. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Transamerica Financial Advisors held 72 shares of Halozyme worth $5.63K as of Q2 2026.
Transamerica Financial Advisors bought 39 Halozyme shares in Q2 2026, an estimated $2.66K.
Halozyme made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #1097 holding.
Transamerica Financial Advisors first reported a position in Halozyme in Q4 2014 and has held it in 10 quarters since.
Transamerica Financial Advisors's Halozyme position peaked at $25K in Q4 2015.
668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.